Spectral AI Reports Q1 2025 R&D Revenue Rise of 6% to $6.7 Million

Reuters
05-14
Spectral AI Reports Q1 2025 R&D Revenue Rise of 6% to $6.7 Million

Spectral AI, Inc. (Nasdaq: MDAI) has announced its financial results for the first quarter ending March 31, 2025. The company reported a 6.0% increase in Research & Development Revenue, reaching $6.7 million, up from $6.3 million in Q1 2024. Additionally, Spectral AI has improved its capital structure, now holding $14.1 million in cash. The company has also completed a debt financing agreement of up to $15.0 million with Avenue Capital Group, including an initial drawdown of $8.5 million in March 2025. This was complemented by a $2.7 million equity raise from institutional and other investors, aimed at supporting the commercialization of the DeepView System in the U.S. Spectral AI continues to work towards its De Novo submission to the FDA, expected in the first half of 2025. The company reiterated its revenue guidance for FY 2025 at approximately $21.5 million, excluding potential contributions from the upcoming commercialization of the DeepView System.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spectral Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9450701-en) on May 13, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10